Fact CheckerSign in

NCT05122013Completed

Remote Intervention for Weight Regain After Sleeve Gastrectomy

A Comprehensive Remote Intervention Program for Weight Regain After Sleeve Gastrectomy: An Open Label Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 30 Dec 2025

Brief summary (registry, in English)

The study is designed to assess the effect of a 3-month remote comprehensive intervention program by a multidisciplinary team combined with mobile supportive text messages aimed to raise the level of happiness and subjective wellbeing, on weight outcomes and physical and behavioral parameters among bariatric surgery patients after sleeve gastrectomy who had a weight regain of ≥10% from nadir, compared to a control group which will receive standard care of a single meeting with the study's registered dietitian at the clinic and then be advised to continue follow up.

Status (registry)
Completed
Study type
Interventional
Enrollment
100 (actual)
First submitted
19 Oct 2021
Start date
18 Feb 2022
Primary completion date
1 Dec 2023
Lead sponsor
Assuta Medical Center
Diseases
Obesity
NCT number
NCT05122013

What you commit to

  • Study type: Interventional
  • Participants enrolled: 100
  • From 18 Feb 2022 to the primary completion date, 1 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of weight loss drug therapy currently or 1-month prior to trial entry.

Other illness

  • Medical contraindications such as active cancer, organ transplant or unbalanced psychiatric disorders.

Other

  • Patients who underwent more than one BS in their past.
  • Currently attending a weight loss program and lost more than 5% of weight at the last month.
  • Current pregnancy and women who gave birth in the last 6 months.

Who the study is looking for

  • Age at the time of BS ≥18 years
  • Patients who underwent primary SG at least 2 years ago and regained at least 10% weight from nadir.
  • Read and speak Hebrew.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Assuta Medical Center
Coordinator of this site? Confirm its status
Tel AvivIsraelUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.